Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERT-AP: Pancrelipase for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency
NCT06477159Phase 4Recruiting
- Sponsor
- The Ohio State University
- Start
- Feb 2024
- Primary completion
- Sep 2027
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of pancrelipase in exocrine pancreatic insufficiency (EPI), sponsored by The Ohio State University. Started Feb 2024; status: recruiting.
02
Drugs
pancrelipase
03
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on NCT06477159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06477159.